Abu Dhabi to launch Rare Diseases Centre of Excellence

It will serve as a flagship hub for diagnosis, amongst others.

The Department of Health – Abu Dhabi (DOH), AstraZeneca and PureHealth signed a Memorandum of Understanding (MOU) to activate a Rare Diseases Centre of Excellence in Abu Dhabi.

The centre will serve as a flagship hub for diagnosis, treatment, follow-ups, research, education and patient care, focusing on rare metabolic, nephrological, and hematologic disorders.

Under the MOU, the Health department, PureHealth and AstraZeneca will collaborate on the activation of the centre, patient access to specialised services, advancement of research, education, and a joint governance framework to oversee delivery and ensure accountability.

The agreement builds directly on the MOU signed by DOH and AstraZeneca at BIO 2024 to establish a Rare Diseases Centre of Excellence in Abu Dhabi.